SCHEMBL214537

SCHEMBL214537

COC(=O)CCN=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3403179 0.87 TSHR (0.56)
SCHEMBL3795395 0.85 TSHR (0.54)
SCHEMBL9714542 0.84 TSHR (0.52)
SCHEMBL9781700 0.84 TSHR (0.52)
SCHEMBL6775802 0.84 TSHR (0.52)
SCHEMBL11437952 0.84 TSHR (0.52)
SCHEMBL10695420 0.82 TSHR (0.50)
SCHEMBL1364810 0.80
SCHEMBL48378 0.78 CYP1A2 (0.45)
SCHEMBL16742415 0.77 HDAC3 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3641826-B1 METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS INC (US) 2023-12-06 EP claimed
US-10772971-B2 Methods of producing drug-carrying polymer scaffolds and protein-polymer-drug conjugates Mersana Therpeutics, Inc. (US) 2020-09-15 US claimed
CN-111315414-A Methods of producing drug-loaded polymer scaffolds and protein-polymer-drug conjugates 梅尔莎纳医疗公司 2020-06-19 CN claimed
EP-3641826-A1 METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES Mersana Therapeutics, Inc. (US) 2020-04-29 EP claimed
WO-2018237262-A1 METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. (US) 2018-12-27 WO claimed
US-20180369405-A1 METHODS OF PRODUCING DRUG-CARRYING POLYMER SCAFFOLDS AND PROTEIN-POLYMER-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. 2018-12-27 US claimed
US-9809822-B2 Triptolide derivatives and preparation method and use thereof HONG KONG BAPTIST UNIVERSITY (HK) 2017-11-07 US claimed
EP-4661913-A1 SELF-STABILIZING LINKER CONJUGATES Beone Medicines I GmbH (CH) 2025-12-17 EP disclosed
US-20250352659-A1 SELF-STABILIZING LINKER CONJUGATES BEONE MEDICINES I GMBH (CH) 2025-11-20 US disclosed
EP-4566670-A2 MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS Gilead Sciences, Inc. (US) 2025-06-11 EP disclosed
EP-3696171-B1 MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS GILEAD SCIENCES INC (US) 2025-02-19 EP disclosed
US-20240297344-A1 NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-05 US disclosed
WO-2024165045-A1 SELF-STABILIZING LINKER CONJUGATES BEIGENE, LTD. (KY) 2024-08-15 WO disclosed
US-4263294-A ANTITUMOUR AGENTS, ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1981-04-21 US disclosed
EP-0024309-A2 Triazolopyridazine derivatives, process and intermediates for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-03-04 EP disclosed
EP-0014402-A1 Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them Takeda Chemical Industries, Ltd. (JP) 1980-08-20 EP disclosed
US-4216216-A TREATING MIGRAINE HEADACHES, ANTI-HISTAMINES HOECHST AKTIENGESELLSCHAFT (DE) 1980-08-05 US disclosed
EP-0011302-A1 Maytansinoids, their production and use Takeda Chemical Industries, Ltd. (JP) 1980-05-28 EP disclosed
EP-0004466-A1 Demethyl maytansinoids and methods for producing them Takeda Chemical Industries, Ltd. (JP) 1979-10-03 EP disclosed
EP-0000220-A1 Dihydrouracils, process for their preparation and pharmaceuticals containing them HOECHST AKTIENGESELLSCHAFT (DE) 1979-01-10 EP disclosed